LATEST NEWS   Muslims in Indonesia to celebrate Aidilfitri on Saturday, March 21 – Religious Affairs Minister | Muslims in Thailand to celebrate Aidilfitri on Saturday - Sheikhul Islam | Muslims in Singapore to celebrate Aidilfitri on Saturday (March 21) - Singapore Mufti | Muslims in Malaysia will celebrate Aidilfitri on Saturday, March 21 - Keeper of the Rulers’ Seal | Ringgit eases to 3.9330/9415 versus US dollar at the close from 3.9145/9205 on Wednesday | 

Refeyn Unveils Mass Photometer To Simplify Sample Quality Assessment

KUALA LUMPUR, March 19 (Bernama) -- Refeyn, a pioneering mass photometry technology developer, has launched the MyMass mass photometer (MyMassMP), a compact instrument designed to simplify sample quality assessment for structural biology.

The device enables researchers to quickly evaluate sample purity, homogeneity and oligomerisation state before proceeding to complex and resource-intensive experiments such as cryo-electron microscopy, native mass spectrometry, bio-layer interferometry and surface plasmon resonance.

“Structural biology and AI-driven drug discovery are moving fast, but they are only as good as the samples that drive them.

“MyMass directly addresses that challenge and marks a significant step forward for Refeyn, putting the power of mass photometry within reach of more researchers than ever before,” said Refeyn Chief Executive Officer, Gerry Mackay in a statement.

Meanwhile, its Chief Product and Marketing Officer, Fiona Coats said the new system builds on strong demand for rapid sample quality assessment tools.

She added that MyMassMP makes this capability more accessible, enabling researchers to determine whether samples are ready for further analysis.

Built on the same core technology as Refeyn’s TwoMP mass photometer, MyMassMP is designed as a self-contained benchtop instrument with an integrated display and onboard data analysis. The system also features dedicated consumables and an intuitive workflow from sample to result.

Refeyn said the launch aims to address a key bottleneck in structural and biophysical research, where poor sample quality remains a leading cause of experimental failure.

-- BERNAMA